Journal profile · Medicine-Dermatology
Piel
ISSN 0213-9251 · eISSN 1578-8830 · Elsevier
Piel: subscription journal; APC about USD 2,290; review about 46 days (submission to acceptance, publisher); 197 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Piel is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, Medicine and Dermatology Studies History and Cancer and Skin Lesions, together about 34.8% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Formación continuada en dermatologíaPiel is a journal oriented towards continuing education in dermatology. For this reason, its interest is not just limited to the Dermatologist, but it also extends to those physicians who started in this speciality, to those who practice outside the large hospital centres, and to those non-specialist physicians that are confronted with dermatological problems in their daily practice. The focus of the journal clearly prioritises continuing education in dermatology, and the updating of topics, taking into account the latest advances that could be of interest to the reader. Articles have to make it easy to identify and assimilate the most relevant aspects of the subject. To achieve this purpose, the journal is structured into sections: Novelties, Reviews,Signs guide/Differential diagnosis, Cases for Diagnosis, The Skin in daily Clinical Practice, Skin in the context of Medicine and its specialities, and Dermatological Therapeutics, among other topics. The journal's Editorial Committee ensures the rigour, quality, the practical interest, and the educational capacity, due to the careful selection of topics and authors, as well as for the variety of tables and illustrations that it uses.Piel es una revista orientada a la formación continuada en dermatología. Por ello, su interés no se limita al dermatólogo, sino que se extiende a los médicos que se inician en esta especialidad, a los que desempeñan sus funciones lejos de los grandes centros hospitalarios, y a aquellos médicos no especialistas que diariamente deben enfrentarse a problemas dermatológicos en su práctica cotidiana. La orientación de la revista prioriza claramente la formación continuada en dermatología y la actualización de los temas, incorporando los últimos avances producidos que puedan ser de interés para el lector. Los artículos han de permitir identificar y asimilar de forma fácil los aspectos más relevantes del tema Para cumplir esta finalidad, la revista está estructurada con las en secciones: Novedades, Revisiones, Signos guía/Diagnóstico diferencial, Casos para el diagnóstico, La Piel en la práctica diaria, La Piel en el contexto de la Medicina y sus especialidades, Terapéutica dermatológica, entre otras. El comité editorial de la revista vela tanto por el rigor, la calidad, el interés práctico y la capacidad didáctica gracias a una cuidada selección de temas y autores como por la variedad de tablas e iconografía que utiliza.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Dermatology
Editor-in-chief Carla FerrándizPublisher website
Editorial board by country: none in mainland China; most named Spain 4 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatology and Skin DiseasesMedicine15.5%
- Medicine and Dermatology Studies HistoryMedicine11.5%
- Cancer and Skin LesionsMedicine7.8%
- Skin Diseases and DiabetesMedicine6.1%
- Nonmelanoma Skin Cancer StudiesMedicine5.3%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology5.2%
- Cutaneous Melanoma Detection and ManagementMedicine5.1%
- Genetic and rare skin diseases.Biochemistry, Genetics and Molecular Biology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Dermatology | Q4 | 143/152 | 6th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.1LetPub ·
- CiteScore (publisher)
- 0.1Publisher website ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.04LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 33OpenAlex ·
- 2-year mean citedness
- 0.03OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 4,524 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 249 | 2 | 71 |
| 2025 | 197 | 1 | 102 |
| 2024 | 183 | 10 | 118 |
| 2023 | 148 | 5 | 161 |
| 2022 | 150 | 17 | 147 |
| 2021 | 240 | 10 | 204 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
46 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 31 daysPublisher website ·
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 46 daysPublisher website ·
- Acceptance to publication
- 140 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,290 / EUR 2,090 / GBP 1,830 / JPY 284,030 | — | — | |
| Publisher website | USD 2,060 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted4
- editorialEditorial. The authors are asked to give a critical opinion on different aspects of the speciality (clinical, therapeutic, research, organisational, teaching), …Length not stated
- history of dermatologyHistory of Dermatology. A review and comments on the different historic aspects of the speciality. It must be accompanied by illustrations associated with their…Length not stated
- opinionEditorial. The authors are asked to give a critical opinion on different aspects of the speciality (clinical, therapeutic, research, organisational, teaching), …Length not stated
- reviewEditorial. The authors are asked to give a critical opinion on different aspects of the speciality (clinical, therapeutic, research, organisational, teaching), …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 0213-9251
- Electronic ISSN
- 1578-8830
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Piel
How long does peer review take at Piel?
The publisher reports about 46 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Piel based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Piel?
According to LetPub and DOAJ records, Piel is indexed in Scopus.
Is Piel open access, and what is the APC?
Piel is a subscription journal. APC about USD 2,290.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .